Faculty & Staff
Dr. Hari Menon
MBBS,MD, DM MEDICAL ONCOLOGY
Professor and HOD of Medical Oncology
Languages
English, Hindi, Tamil, Malayalam
- Overview
- Projects
- Publications
- Other Contributions
Professor and HOD
Qualification/ Education
Sl# Degree / Qualification Institution Year Place 1 MBBS Government Medical College 1987 – 1993 Thiruvananthapuram, Kerala 2 Rotating Internship Government Medical College 1993 – 1994 Thiruvananthapuram, Kerala 3 MD (Internal Medicine) Seth G.S. Medical College & KEM Hospital 1996 – 1999 Mumbai 4 DM (Medical Oncology) AIIMS – IRCH 2001 – 2004 New Delhi
Experience
Sl# Designation Hospital / Institution Year Place 1 Junior Resident (Internal Medicine) V.S.S. Medical College May 1995 – Dec 1995 Sambalpur, Orissa 2 Registrar (Medical Oncology & BMT) Tata Memorial Hospital Apr 1999 – Jan 2001 Mumbai 3 Senior Resident (Medical Oncology) AIIMS – IRCH Jan 2004 – Sep 2004 New Delhi 4 Professor & Convener, Adult Hemato-lymphoid Unit Tata Memorial Hospital Nov 2004 – Aug 2016 Mumbai 5 Senior Consultant & Director, Hemato-Oncology and SCT Program Cytecare Cancer Centre Aug 2016 – Oct 2021 Bangalore 6 Professor, Hematology & Medical Oncology (Faculty) St. Johns Medical College 2021 – Present Bangalore
| Sl# | Designation | Hospital / Institution | Year | Place |
| 1 | Junior Resident (Internal Medicine) | V.S.S. Medical College | May 1995 – Dec 1995 | Sambalpur, Orissa |
| 2 | Registrar (Medical Oncology & BMT) | Tata Memorial Hospital | Apr 1999 – Jan 2001 | Mumbai |
| 3 | Senior Resident (Medical Oncology) | AIIMS – IRCH | Jan 2004 – Sep 2004 | New Delhi |
| 4 | Professor & Convener, Adult Hemato-lymphoid Unit | Tata Memorial Hospital | Nov 2004 – Aug 2016 | Mumbai |
| 5 | Senior Consultant & Director, Hemato-Oncology and SCT Program | Cytecare Cancer Centre | Aug 2016 – Oct 2021 | Bangalore |
| 6 | Professor, Hematology & Medical Oncology (Faculty) | St. Johns Medical College | 2021 – Present | Bangalore |
No areas of interest specified.
No groups and associations specified.
No project details available.
| S.I. No | Publication Title | Authors | Source | Year |
|---|---|---|---|---|
| 1 | Avascular necrosis of head of femur in a patient with acute promyelocytic leukemia. | Abhyankar D, Nair R, Menon H, Kapoor B, Advani S. | Leuk Lymphoma | 2000 |
| 2 | Clinical Perspectives on Amyloidosis in India: A Systematic Literature Review | Mirgh S, Yanamandra U, Vishvanathan GK, Gundeti S, Khattry N, John MJ, Malhotra P, Menon H, Das S, Nair R, Nair V, Saikia T, Kumar SK. | Clin Lymphoma Myeloma Leuk | 2025 |
| 3 | Real World Outcomes with Treatment Free Remission in Chronic Myeloid Leukemia-Experience from a Tertiary Care Cancer Centre | Sarma RJ, Kashyap L, Srikanth A, Mondal T, Kashyap Y, Nandhana R, Bondili SK, Bonda A, Nayak L, Chatterjee G, Jain H, Patkar NV, Tembhare P, Subramanian P, Gujral S, Sengar M, Menon H, Nair R, Bagal B. | Indian J Hematol Blood Transfus . | 2024 |
| 4 | Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings | Menon H, Singh PK, Bagal B, Dolai T, Jain A, Chaudhri A. | Indian J Hematol Blood Transfus . | 2023 |
| 5 | Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry | Nair R, Bhurani D, Rajappa S, Kapadia A, Reddy Boya R, Sundaram S, Menon H, Raman GS, Seshachalam A, Nimmagadda R | Front Oncol | 2022 |
| 6 | Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in India | Das S, Bagal B, Jain H, Kashyap L, Anbarasan S, Abhishek S, Bondili S, Nayak L, Thorat J, Mirgh S, Gokarn A, Punatar S, Ayushi S, Epari S, Tembhare P, Shetty P, Khanna N, Goda J, Aliasgar M, Gupta T, Sengar M, Khattry N, Laskar S, Menon H | Indian J Hematol Blood Transfus . | 2022 |
| 7 | Real world outcomes of Hodgkin’s Lymphoma: A multicentric registry from India. | Bhurani D, Nair R, Rajappa S, Rao SA, Sridharan N, Boya RR, Raman GS, Menon H, Seshachalam A, Nimmagadda R | Front Oncol | 2022 |
| 8 | Mantle cell lymphoma: Clinical review of changing treatment paradigms with the advent of Novel therapies and an insight into Indian data. | Radhakrishnan VS, Lokireddy P, Parihar M, Prakash PS, Menon H. | Cancer Rep (Hoboken) | 2022 |
| 9 | Impact of COVID-19 on cancer care in India: a cohort study | Ranganathan P, Sengar M, Chinnaswamy G, Agrawal G, Arumugham R, Bhatt R, Bilimagga R, Chakrabarti J, Chandrasekharan A, Chaturvedi HK, Choudhrie R, Dandekar M, Das A, Goel V, Harris C, Hegde SK, Hulikal N, Joseph D, Kantharia R, Khan A, Kharde R, Khattry N, Lone MM, Mahantshetty U, Malhotra H, Menon H, Mishra D, Nair RA, Pandya SJ, Patni N, Pautu J, Pavamani S, Pradhan S, Thammineedi SR, Selvaluxmy G, Sharan K, Sharma BK, Sharma J, Singh S, Srungavarapu GC, Subramaniam R, Toprani R, Raman RV, Badwe RA, Pramesh CS; | Lancet Oncol . | 2021 |
| 10 | Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experienc | Jain H, Kapoor A, Sengar M, Chanana R, Menon H, Sridhar E, Laskar S, Agarwal A, Shastri J, Khanna N, Rangarajan V, Bagal B, Thorat J, Shet T, Gujral S. | Indian J Hematol Blood Transfus | 2021 |
| 11 | Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML) | Patkar N, Kakirde C, Shaikh AF, Salve R, Bhanshe P, Chatterjee G, Rajpal S, Joshi S, Chaudhary S, Kodgule R, Ghoghale S, Deshpande N, Shetty D, Khizer SH, Jain H, Bagal B, Menon H, Khattry N, Sengar M, Tembhare P, Subramanian P, Gujral S. | Leukemia | 2021 |
| 12 | Sequential Treatment of Arsenic Trioxide Followed by All Trans Retinoic Acid with Anthracyclines has Excellent Long-Term Cure in Acute Promyelocytic Leukemia | Devadas SK, Jain H, Bagal B, Sengar M, Dangi U, Khattry N, Amre P, Patkar N, Subramaniam PG, Nair R, Menon H. | Indian J Hematol Blood Transfus | 2020 |
| 13 | ISNO Position Statement on Treatment Guidance in Neuro-oncology During Pandemics | Gupta T, Singh VP, Balasubramian A, Menon H, Kurkure PA, Kumar S, Jalali R. | Neurol India | 2020 |
| 14 | . Providing Ancillary Care in Clinical Research: A Case of Diffuse Large B-Cell Lymphoma during a Malaria Vaccine Trial in Equatorial Guinea | Manock SR, Mtoro A, Urbano Nsue Ndong V, Olotu A, Chemba M, Sama Roca AE, Eburi E, García GA, Cortes Falla C, Niemczura de Carvalho J, Contreras J, Saturno B, Riocalo JD, Nze Mba JL, Koka R, Lee ST, Menon H, Church LWP, Ayekaba MO, Billingsley PF, Abdulla S, Richie TL, Hoffman SL | Am J Trop Med Hyg | 2020 |
| 15 | Outcomes of T-lymphoblastic lymphoma treated with pediatric ALL-like protocol | Sengar M, Carr R, Jain H, Chanana R, Rangarajan V, Sridhar E, Shet T, Menon H, Gujral S, Laskar S. | Indian J Cancer | 2020 |
| 16 | A Prospective Observational Multi-institutional Study on Invasive Fungal Infections Following Chemotherapy for Acute Myeloid Leukemia (MISFIC Study): A Real World Scenario from India | George B, Menon H, Bhurani D, Damodar S, Apte S, Seth T, Sharma A, Shyam R, Malhotra P, Easow J, Lakshmi KM, Agrawal N, Sengar M, Nataraj KS, Ahmed R, Sharma S, Khadwal A, Prakash G, Abraham A, Devasia A, Korula A, Mathews V. | Indian J Hematol Blood Transfus . | 2019 |
| 17 | Utility of flouro-deoxy-glucose positron emission tomography/computed tomography in the diagnostic and staging evaluation of patients with primary CNS lymphoma. | Gupta M, Gupta T, Purandare N, Rangarajan V, Puranik A, Moiyadi A, Shetty P, Epari S, Sahay A, Mahajan A, Janu A, Bagal B, Menon H, Kannan S, Krishnatry R, Sastri GJ, Jalali R | CNS Oncol. | 2019 |
| 18 | Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World Contex | Patkar N, Kakirde C, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Deshpande N, Kadechkar S, Chatterjee G, Kannan S, Shetty D, Gokarn A, Punatkar S, Bonda A, Nayak L, Jain H, Bagal B, Menon H, Sengar M, Khizer SH, Khattry N, Tembhare P, Gujral S, Subramanian P | Front Oncol | 2019 |
| 19 | Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia. | Patkar N, Kodgule R, Kakirde C, Raval G, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Kadechkar S, Khizer SH, Kannan S, Shetty D, Gokarn A, Punatkar S, Jain H, Bagal B, Menon H, Sengar M, Khattry N, Tembhare P, Subramanian P, Gujral S. | Oncotarget | 2018 |
| 20 | BRAFV600E mutation in hairy cell leukemia: A single-center experience | Bibi A, Java S, Chaudhary S, Joshi S, Mascerhenas R, Rabade N, Tembhare P, Subramanian PG, Gujral S, Menon H, Khattry N, Sengar M, Bagal B, Jain H, Patkar N | Indian J Pathol Microbiol | 2018 |
| 21 | Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group. | Nair R, Kakroo A, Bapna A, Gogia A, Vora A, Pathak A, Korula A, Chakrapani A, Doval D, Prakash G, Biswas G, Menon H, Bhattacharya M, Chandy M, Parihar M, Vamshi Krishna M, Arora N, Gadhyalpatil N, Malhotra P, Narayanan P, Nair R, Basu R, Shah S, Bhave S, Bondarde S, Bhartiya S, Nityanand S, Gujral S, Tilak TVS, Radhakrishnan V | Indian J Hematol Blood Transfus. | 2018 |
| 22 | Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiences | Modkharkar S, Navale P, Amare PK, Chougule A, Patkar N, Tembhare P, Menon H, Sengar M, Khattry N, Banavali S, Arora B, Narula G, Laskar S, Khanna N, Muckaden MA, Rangarajan V, Agrawal A, Shet T, Epari S, Subramanian PG, Gujral S. | Indian J Pathol Microbiol | 2018 |
| 23 | Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit | Khattry N, Laskar S, Sengar M, Rangarajan V, Shet T, Subramanian PG, Epari S, Bagal B, Goda JS, Agarwal A, Jain H, Tembhare P, Patkar N, Khanna N, Punatar S, Gokarn A, Shetty D, Jain H, Bonda A, Gota V, Hasan S, Kode J, Dutt S, Kulkarni S, Shetty N, Sable N, Deodhar J, Jadhav S, Pawaskar P, Mathew L, Menon H, Nair R, Kannan S, Chiplunkar S, Gujral S | Indian J Cancer | 2018 |
| 24 | Demographic profile, clinicopathological spectrum, and treatment outcomes of primary central nervous system tumors: Retrospective audit from an academic neuro-oncology unit | Gupta T, Epari S, Moiyadi A, Shetty P, Goda JS, Krishnatry R, Chinnaswamy G, Vora T, Menon H, Patil V, Sahay A, Bano N, Jalali R | Indian J Cancer | 2017 |
| 25 | Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases | Agrawal K, Shet T, Sridhar E, Dhende S, Sengar M, Arora B, Laskar S, Gujral S, Menon H, Banavali S. | Indian J Pathol Microbiol. | 2017 |
| 26 | Non-adherence to CML therapy and its clinical implications in India. | Hari Menon | Natl Med J India. | 2017 |
| 27 | Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference. | Yanamandra U, Khattry N, Kumar S, Raje N, Jain A, Jagannath S, Menon H, Kumar L, Varma N, Varma S, Saikia T, Malhotra P | Indian J Hematol Blood Transfus . | 2017 |
| 28 | Immunogenetics of chronic lymphocytic leukemia | Patkar N, Rabade N, Kadam PA, Mishra F, Muranjan A, Tembhare P, Chaudhary S, Joshi S, Jain H, Dangi U, Bagal B, Khattry N, Menon H, Gujral S, Sengar M, Subramanian PG. | Indian J Pathol Microbiol. | 2017 |
| 29 | A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer | Glisson B, Besse B, Dols MC, Dubey S, Schupp M, Jain R, Jiang Y, Menon H, Nackaerts K, Orlov S, Paz-Ares L, Ramlau R, Tang R, Zhang Y, Zhu M. A | Clin Lung Cancer | 2017 |
| 30 | Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance | Patkar N, Ghodke K, Joshi S, Chaudhary S, Mascerhenas R, Dusseja S, Mahadik S, Gaware S, Tembhare P, Gujral S, Kabre S, Kadam-Amare P, Jain H, Dangi U, Bagal B, Khattry N, Sengar M, Arora B, Narula G, Banavali S, Menon H, Subramanian PG | Leuk Lymphoma . | 2016 |
| 31 | Population pharmacokinetics of Reditux™, a biosimilar Rituximab, in diffuse large B-cell lymphoma | Gota V, Karanam A, Rath S, Yadav A, Tembhare P, Subramanian P, Sengar M, Nair R, Menon H. | Cancer Chemother Pharmacol . | 2016 |
| 32 | Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think? | Verma A, Shet T, Epari S, Gupta M, Gujral S, Khanna N, Laskar S, Sengar M, Arora B, Menon H, Banavali S. | Int J Surg Pathol . | 2016 |
| 33 | A retrospective study of correlation of morphologic patterns, MIB1 proliferation index, and survival analysis in 134 cases of plasmacytoma | Ghodke K, Shet T, Epari S, Sengar M, Menon H, Gujral S. | Ann Diagn Pathol . | 2015 |
| 34 | Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia | Agarwal MB, Malhotra H, Chakrabarti P, Varma N, Mathews V, Bhattacharyya J, Seth T, Gayathri K, Menon H, Subramanian PG, Sharma A, Bhattacharyya M, Mehta J, Vaid AK, Shah S, Aggarwal S, Gogoi PK, Nair R, Agarwal U, Varma S, Prasad SV, Manipadam MT. | Indian J Med Paediatr Oncol . | 2015 |
| 35 | Treatment results in advanced stage Hodgkin's lymphoma: a retrospective study | H Jain 1 , M Sengar, R Nair, H Menon, S Laskar, T Shet, S Gujral, E Sridhar | J Postgrad Med . | 2015 |
| 36 | Extranodal natural killer/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India | Shet T, Suryawanshi P, Epari S, Sengar M, Rangarajan V, Menon H, Laskar S. | Leuk Lymphoma . | 2014 |
| 37 | A simplified scoring system to document variant patterns in nodular lymphocyte predominant Hodgkin lymphoma | Tanuja Shet 1 , Poonam Panjwani, Sridhar Epari, Manju Sengar, Maya Prasad, Brijesh Arora, Siddhartha Laskar, Sumeet Gujral, Hari Menon, Shripad Banavali | Leuk Lymphoma . | 2015 |
| 38 | Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors | Sung-Hyun Kim 1 , Hari Menon 2 , Saengsuree Jootar 3 , Tapan Saikia 4 , Jae-Yong Kwak 5 , Sang-Kyun Sohn 6 , Joon Seong Park 7 , Seong Hyun Jeong 7 , Hyeoung Joon Kim 8 , Yeo-Kyeoung Kim 8 , Suk Joong Oh 9 , Hawk Kim 10 , Dae Young Zang 11 , Joo Seop Chung 12 , Ho Jin Shin 12 , Young Rok Do 13 , Jeong-A Kim 14 , Dae-Young Kim 15 , Chul Won Choi 16 , Sahee Park 17 , Hye Lin Park 18 , Gong Yeal Lee 18 , Dae Jin Cho 18 , Jae Soo Shin 18 , Dong-Wook Kim 19 | Haematologica . | 2014 |
| 39 | Dengue fever as a cause of febrile neutropenia in adult acute lymphoblastic leukemia: a single center experience | Jain H, Sengar M, Menon H, Dangi U, Biswas S, Chandrakanth MV. | Hematol Oncol Stem Cell Ther . | 2014 |
| 40 | Blastic plasmacytoid dendritic cell neoplasm: a rare subtype of myeloid leukemia | Hasmukh Jain 1 , Manju Sengar 2 , Hari Menon 2 , M V Chandrakanth 2 | Hematol Oncol Stem Cell Ther | 2014 |
| 41 | Issues in current management of chronic myeloid leukemia: Importance of molecular monitoring on long term outcome | Dr. Hari menon | South Asian J Cancer . | 2013 |
| 42 | Therapeutic drug monitoring for imatinib: Current status and Indian experience | Brijesh Arora 1 , Vikram Gota 2 , Hari Menon 1 , Manju Sengar 1 , Reena Nair 1 , Pankaj Patial 2 , S D Banavali 1 | Indian J Med Paediatr Oncol . | 2013 |
| 43 | Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis | Partha Sarathi Roy 1 , Shiji John 1 , Sadashiv Karankal 2 , Sadhana Kannan 2 , Preeti Pawaskar 1 , Jayanta Gawande 1 , Bhausaheb Bagal 1 , Navin Khattry 1 , Manju Sengar 1 , Hari Menon 1 , Sumeet Gujral 3 , Reena Nair 4 | Indian J Med Paediatr Oncol | 2013 |
| 44 | Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible? | Siddhartha Laskar 1 , Deepak P Kumar, Nehal Khanna, Hari Menon, Manju Sengar, Brijesh Arora, Sumeet Gujral, Tanuja Shet, Epari Sridhar, Venkatesh Rangarajan, Mary Ann Muckaden, Reena Nair, Shripad Banavali | Leuk Lymphoma . | 2014 |
| 45 | Prevalence and patterns of cytomegalovirus DNAemia in adult patients with acute lymphoblastic leukemia on chemotherapy | S. Gulia, U. Dangi, S. Biswas, R. Kelkar, H. Menon, M. Sengar | Leukemia and Lymphoma | 2013 |
| 46 | Is there a role for metronomic induction (and maintenance) therapy in elderly patients with acute myeloid leukemia? A literature review | N Tandon 1 , S Banavali, H Menon, S Gujral, P A Kadam, A Bakshi | Indian J Cancer | 2013 |
| 47 | Sunitinib in metastatic renal cell carcimoma: a single-center experience | V M Krishna 1 , V Noronha, K Prabhash, A Joshi, V Patil, B Bhosale, T Ravi, H Menon, S Gupta, S D Banavali, G Bakshi, H B Tangaonkar | Indian J Cancer | 2013 |
| 48 | A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India | M P Jadhav 1 , V M Shinde, S Chandrakala, F Jijina, H Menon, B Arora, P A Kurkure, P M Parikh, N A Kshirsagar | Indian J Cancer | 2012 |
| 49 | Morphological spectrum of leukemic mantle cell lymphoma | Khaliqur Rahman 1 , P G Subramanian, Pratibha Amare Kadam, Vijaya Gadage, Komal Galani, Neha Mittal, Sitaram Ghogale, Yajamanam Badrinath, Rashida Ansari, Shilpa Kushte, Reena Nair, Manju Sengar, Hari Menon, Sumeet Gujral | Indian J Pathol Microbiol. | 2012 |
| 50 | Parenthood in patients with acute promyelocytic leukemia after treatment with arsenic trioxide: a case series | Shilpa Gupta 1 , Bhausaheb Bagel, Sumeet Gujral, P G Subramanian, Navin Khattry, Hari Menon, Reena Nair | Leuk Lymphoma . | 2012 |
| 51 | Clinicopathologic study and outcome analysis of thyroid lymphomas: experience from a tertiary cancer center | Rakesh Katna 1 , Tanuja Shet, Manju Sengar, Hari Menon, Siddharth Laskar, Kumar Prabhash, Anil D'Cruz, Reena Nair | Head neck | 2012 |
| 52 | Characterization of cryptic rearrangements, deletion, complex variants of PML, RARA in acute promyelocytic leukemia | Pratibha Kadam Amare 1 , Chanda Baisane, Reena Nair, Hari Menon, Shripad Banavali, Sharayu Kabre, Sumit Gujral, P Subramaniam | Indian J Hum Genet | 2011 |
| 53 | A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center | Manju Sengar 1 , A Akhade, R Nair, H Menon, T Shet, S Gujral, E Sridhar, S Laskar, M Muckaden | Indian J Med Paediatr Oncol . | 2011 |
| 54 | Histopathological audit of splenectomies received at a cancer hospital | Sumeet Gujral 1 , Poornima Lad, P G Subramanian, T M Shet, S Epari, S Laskar, M Muckaden, H Menon, M Sengar, R Nair | Indian J Pathol Microbiol. | 2011 |
| 55 | Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts | Kedar K Deodhar 1 , R A Kerkar, Pallavi Suryawanshi, Hari Menon, Santosh Menon | J Cancer Res Ther | 2011 |
| 56 | A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer | G R Blumenschein Jr 1 , F Kabbinavar 2 , H Menon 3 , T S K Mok 4 , J Stephenson 5 , J T Beck 6 , K Lakshmaiah 7 , K Reckamp 8 , Y-J Hei 9 , K Kracht 10 , Y-N Sun 11 , R Sikorski 9 , L Schwartzberg 12 ; Motesanib NSCLC Phase II Study Investigators | Ann Oncol | 2011 |
| 57 | Lymphoma masquerading as acute leukemia-mystery unfolded | P Jain, K Prabhash, H Menon, S Gupta, P M Parikh | Indian J Cancer | 2010 |
| 58 | Validation of recursive partitioning analysis classification in patients with brain metastases from non-small cell lung cancer treated with short-course accelerated radiotherapy | J P Agarwal 1 , T Wadasadawala, A Munshi, P Chadda, R Apsani, M Upasani, S G Laskar, C S Pramesh, G Karimundackal, H Menon, K Prabhash, N Jambhekar | Clin Oncol (R Coll Radiol) | 2010 |
| 59 | Isolated central nervous system involvement by lymphomatoid granulomatosis in an adolescent: a case report and review of literature | Tejpal Gupta 1 , Tabassum Wadasadawala, Tanuja Shet, Rakesh Jalali, Hari Menon | Pediatr Hematol Oncol | 2010 |
| 60 | Primary endobronchial synovial sarcoma confirmed by SYT-SSX1 fusion gene transcript by reverse transcriptase polymerase chain reaction | Kumar Rajiv, Menon Santosh, Desai Sangeeta, Pramesh C, Menon Hari, Jambhekar Nirmala | Indian Journal of Pathology and Microbiology | 2009 |
| 61 | Immunophenotypic profile of acute leukemia: critical analysis and insights gained at a tertiary care center in India | S Gujral 1 , Y Badrinath, A Kumar, P G Subramanian, G Raje, H Jain, A Pais, P S Amre Kadam, S D Banavali, B Arora, P Kumar, V G Hari Menon, P A Kurkure, P M Parikh, S Mahadik, A B Chogule, S C Shinde, C N Nair | Cytometry B Clin Cytom | 2009 |
| 62 | Case report: Second primary small cell carcinoma of the trachea in a breast cancer survivor: a case report and literature review | S Jain 1 , J P Agarwal, T Gupta, P M Parikh, R C Mistry, H Menon, C S Pramesh, S K Shrivastava | Br J Radiol | 2008 |
| 63 | Bronchoalveolar carcinoma of lung masquerading as iodine avid metastasis in a patient with minimally invasive follicular carcinoma of thyroid | Gaurav Malhotra 1 , Narendra Nair, Hari Menon, Sumit Gujral, Amit Abhyankar, Nawab S Baghel, Sushama Awasare, Swapna J Nabar, Suman Abhyankar, Purushottam G Kand | Clin Nucl Med | 2008 |
| 64 | Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience | R Jalali 1 , A Basu, T Gupta, A Munshi, H Menon, R Sarin, A Goel | Br J Neurosurg | 2007 |
| 65 | Brain metastasis--evidence based management | G Biswas 1 , R Bhagwat, R Khurana, H Menon, N Prasad, P M Parikh | J Cancer Res Ther | 2006 |
| 66 | Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide | Rakesh Jalali 1 , Pritanjali Singh, Hari Menon, Sumeet Gujral | J Neurooncol | 2007 |
| 67 | Chronic myeloid leukemia presenting as paraneoplastic ocular myasthenia gravis | P Kumar, P Jain, H Menon, P Purvish | Ann Oncol | 2007 |
| 68 | Rituximab (anti-CD20 monoclonal antibody) in lymphoproliferative malignancies: Tata Memorial experience | G Biswas 1 , P M Parikh, R Nair, R Bhagwat, A Bakshi, K Prabhash, A Vora, S Gupta, V R Pai, H Menon, P S R K Sastry | J Assoc Physicians India | 2006 |
| 69 | Pregnancy outcome of two patients treated with imatinib | K Prabhash, P S R K Sastry, G Biswas, A Bakshi, N Prasad, H Menon, P M Parikh | Ann Oncol | 2005 |
| 70 | High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma | Lalit Kumar 1 , G M K Raju, K Ganessan, S Shawgi, H Menon, J Wadhwa, A Sharma, Rajveer Singh, V Kochupillai | Natl Med J India. | 2003 |
| 71 | Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin's lymphoma and corrected with IVIG | T K Saikia, H Menon, S H Advani | Ann Oncol | 2001 |
| 72 | Clinico-pathological profile of Hairy cell leukemia: critical insights gained at a tertiary care cancer hospital | Komal S Galani 1 , P G Subramanian, Vijaya S Gadage, Khaliqur Rahman, M S Ashok Kumar, Shaila Shinde, Shashikant Mahadik, Rashida Ansari, Manju Sengar, Hari Menon, Reena Nair, Sumeet Gujral | Indian J Pathol Microbiol . | 2012 |
| 73 | Nodular lymphocyte predominant Hodgkin lymphoma and diphenylhydantoin: Report of a case and review of the literature | Sharma, Shobhna1; Menon, Hari2; Sengar, Manju2; Gujral, Sumeet1 | Indian Journal of Pathology and Microbiology | 2013 |
| 74 | STI-571 (Gleavec) in the treatment of chronic myeloid leukaemia | . Kumar L, Kumari M, Menon H. | The National Medical Journal of India | 2002 |
| 75 | Treatment free remission (TFR) in chronic myeloid leukemia—results, compliance and patterns of failure from a tertiary care cancer centre in India | Sachin Punatar, Nishant Jindal, Anant Gokarn, Sumeet Mirgh, Akanksha Chichra, Lingaraj Nayak, Bhausaheb Bagal, Papagudi Subramanian, Prashant Tembhare, Nikhil Patkar, Gaurav Chatterjee, Sweta Rajpal, Sadhana Kannan, Vinod Hande, Komal Kumbhalwar, Swapnil Chavan, Hari Menon & Navin Khattry | blood cancer journal | 2025 |
| 76 | The Rs 100 "R+Cu" (resveratrol and copper) anti-cancer magic tablet controversy: Results of online survey among oncologists | Purvish M Parikh 1 , Narayanan Prasad 2 , Raja Thirumalairaj 3 , Prasanta R Mohapatra 4 , Viraj Lavingya 5 , Hari Menon 6 , Ajay Bapna 7 , Prakash Chitalkar 8 , Govind B Kanakasetty 9 , Vineet G Gupta 10 , Arun Chandrasekharan 11 , Indu B Aggarwal 12 , Amish Vora 13 | Indian J Cancer . | 2025 |
No Others Contributions details available.